Jay Glenn Wohlgemuth

Form D signer

Jay Glenn Wohlgemuth

Chief Executive Officer at Pacegenix

Form D signer

Capital raised by Pacegenix

$22.5M+$22.5M latest round

1 Form D filing · first filed Mar 2026 · Cambridge, MA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2024
30D INTEREST: —

Career

1 company on file · founded 2024

PacegenixBiotech · Cambridge, MAsince 2024

Chief Executive Officer

Signatory on Pacegenix's Form D filings · $22.5M raised across 1

Company filings

via EDGAR · Form D for Pacegenix1

DateCompanyFormAmountRole on filing

Mar 11, 2026PacegenixForm D+$22.5MChief Executive Officer

Form DMar 11, 2026 · Pacegenix+$22.5Mas Chief Executive Officer

Overview

Last filing Mar 11, 2026

Jay Glenn Wohlgemuth is on file as Chief Executive Officer at Pacegenix in Cambridge, MA. Pacegenix has 1 Form D filing on record, $22.5M raised in total. Jay Glenn Wohlgemuth appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Pacegenix · 1

Frank Grazzini, IIExecutive Officer

Products

Pacegenix · 1

PACE-101Cardiovascular therapeutic (drug candidate)

A rhythm-control drug candidate targeting atrial fibrillation in patients with hypertrophic cardiomyopathy (AF-HCM).